Stay up-to-date with all of the life science events taking place in Vancouver with the Science in Vancouver events calendar! From academia to industry and biotech to pharma, our events calendar is your complete source for life science conferences, symposiums, networking, and workshops in Vancouver. We even cover science pub nights and science fundraisers!

If you’re interested in promoting your life science event on the Science in Vancouver events calendar, please use our event submission form.

Loading Events

« All Events

  • This event has passed.

What Has Gone Wrong with Publication Practices?

May 31, 2022, 2022

Event Navigation

As in several other scientific disciplines, pharmaceutical sciences, and in particularly nanomedicine is experiencing a reproducibility crisis [1]. This crisis has multiples roots, and can be in part explained by the use of ever more complex experimental protocols and specialized systems [2], inaccurate or incomplete description of methods employed and lack of rigor in the design of experimental plan.  However, another aspect that should not be ignored, and that possibly contributes to exacerbating this problem is the drift which is currently occurring in the publication practices, where for some groups, sharing scientific findings ceases to be the primary reason for publishing their research findings. Using examples taken mainly from the field of drug delivery, this presentation aims at analyzing the subtle causes that may contribute to the lack of reproducibility of the scientific literature and its impact on the society. It will also provide some possible solutions to disseminate new knowledge in a more reliable fashion.


[1]. Leroux JC, Angew. Chem. Int. Ed. 2017, 56, 15170-15171.

[2]. Leroux JC, J Control. Release 2018, 278, 140-141.

Dr. Jean-Christophe Leroux is a full professor of Drug Formulation and Delivery and head of the Institute of Pharmaceutical Sciences at the ETH Zurich, Switzerland. He has made important fundamental and applied contributions to the fields of biomaterials and drug delivery, and has been involved in the development of innovative bio-detoxification systems for the treatment of metabolite disorders. He is a fellow of the AAPS, EURASC and the CRS, and the co-founder of the start-up pharmaceutical companies Versantis AG and Inositec AG.


May 31, 2022
9:00 am - 10:30 am




NanoMedicines Innovation Network